Howard J. Weisman - 29 Jan 2024 Form 4 Insider Report for PaxMedica, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Jan 2024
Net transactions value
-$175
Form type
4
Filing time
31 Jan 2024, 17:16:35 UTC
Previous filing
29 Nov 2023
Next filing
14 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Sale $175 -372 -0.98% $0.4700 37,675 29 Jan 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
F2 The sale price represents the weighted average sale price of the shares sold ranging from $0.47 to $0.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.